BARD markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities.

BARD pioneered the development of single-patient-use medical products for hospital procedures; today BARD is dedicated to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall costs.

BARD,s core values of Quality, Integrity, Service, and Innovation represent our reality and our aspirations. These four values prepare us for the challenges ahead and guide our everyday activities and align us to our mission. They are central to how we behave and want to be viewed by our fellow co-workers, customers, shareholders and communities.

BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Our mission is to improve and expand the treatment available of congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive, catheter-based approaches.

Developing Tools for Dental and Medical since 1971. Swiss precision engineering since 1971. Nouvag AG develops and produces all of its great products in Switzerland.

Vascular Innovations Co. Ltd is a medical device company primarily involved in the manufacture of occlusion devices. It also distributes devices from other manufactures relating to the coronary system.

The corporate office and manufacturing facility is located in Nonthaburi, Thailand. The company manufactures and sells directly to the Thailand market. Its devices are made available in the international market through a wide network of distributors. As part of the expansion process it is continously negotiating with international distributors.


New technology coming soon:

InterVene, Inc. is developing the first non-implant-able, catheter-based therapy to treat the valvular pathophysiology of chronic venous.